These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30394649)

  • 1. Generation of a pregnancy cohort for medicine utilisation and medicine safety studies in New Zealand.
    Donald S; Barson D; Horsburgh S; Sharples K; Parkin L
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1335-1343. PubMed ID: 30394649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005-2015.
    Donald S; Sharples K; Barson D; Horsburgh S; Parkin L
    Eur J Clin Pharmacol; 2020 Jun; 76(6):887-896. PubMed ID: 32248249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of using primary care electronic medical records in the UK to study medications in pregnancy.
    Cea-Soriano L; García Rodríguez LA; Fernández Cantero O; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):977-85. PubMed ID: 23813653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France.
    Blotière PO; Weill A; Dalichampt M; Billionnet C; Mezzarobba M; Raguideau F; Dray-Spira R; Zureik M; Coste J; Alla F
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):763-770. PubMed ID: 29763992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of prescription medicine dispensing before and during pregnancy in New Zealand, 2005-2015.
    Donald S; Sharples K; Barson D; Horsburgh S; Parkin L
    PLoS One; 2020; 15(6):e0234153. PubMed ID: 32484824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare databases in Europe for studying medicine use and safety during pregnancy.
    Charlton RA; Neville AJ; Jordan S; Pierini A; Damase-Michel C; Klungsøyr K; Andersen AM; Hansen AV; Gini R; Bos JH; Puccini A; Hurault-Delarue C; Brooks CJ; de Jong-van den Berg LT; de Vries CS
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):586-94. PubMed ID: 24664855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic drug exposure in pregnancy and pregnancy outcome from national drug usage data.
    Richards N; Reith D; Stitely M; Smith A
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):84. PubMed ID: 29625554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996-2006.
    Artama M; Gissler M; Malm H; Ritvanen A;
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):729-38. PubMed ID: 21626607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data.
    Wentzell N; Schink T; Haug U; Ulrich S; Niemeyer M; Mikolajczyk R
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1005-1010. PubMed ID: 30022557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD).
    Mikolajczyk RT; Kraut AA; Garbe E
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):873-80. PubMed ID: 23733705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?
    Hurault-Delarue C; Chouquet C; Savy N; Lacroix I; Beau AB; Montastruc JL; Damase-Michel C
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):770-7. PubMed ID: 27018245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry.
    Shahir AK; Briggs N; Katsoulis J; Levidiotis V
    Nephrology (Carlton); 2013 Apr; 18(4):276-84. PubMed ID: 23441694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women.
    Cleary BJ; Butt H; Strawbridge JD; Gallagher PJ; Fahey T; Murphy DJ
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):408-17. PubMed ID: 20099251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of drugs with pregnancy exposure registries during pregnancy.
    Illoh OA; Toh S; Andrade SE; Hampp C; Sahin L; Gelperin K; Taylor L; Bird ST
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):604-611. PubMed ID: 29516585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.
    Taylor LG; Thelus Jean R; Gordon G; Fram D; Coster T
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):510-7. PubMed ID: 25833769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and patterns of antidepressant drug use during pregnancy.
    Ververs T; Kaasenbrood H; Visser G; Schobben F; de Jong-van den Berg L; Egberts T
    Eur J Clin Pharmacol; 2006 Oct; 62(10):863-70. PubMed ID: 16896784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of missing prescriptions in commercial claims databases: results of a cohort study.
    Cepeda MS; Fife D; Denarié M; Bradford D; Roy S; Yuan Y
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):386-392. PubMed ID: 28120552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
    Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015.
    Engeland A; Bjørge T; Klungsøyr K; Hjellvik V; Skurtveit S; Furu K
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):995-1004. PubMed ID: 29920833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.